INSM · Healthcare · $23.5B
After-hours $109.11+0.48%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“브린수프리 매출 3억920만 달러 — 전 분기 대비 49% 성장했어요.”
In the company's words · 2026 2분기 earnings call